Considering Wegovy and concerned about cost? Ask your insurer and care team about coverage, the full cost of treatment, and appropriate medication options. Earlier pricing and compounded-semaglutide program details from this 2023 article are outdated and have been removed.
What changed after the semaglutide shortage?
The FDA determined that the national shortage of semaglutide injection products was resolved on February 21, 2025. The temporary enforcement-discretion periods tied to that shortage have ended. The shortage-based explanation in the original article should no longer be used to describe current access to compounded semaglutide. See the FDA’s updates on GLP-1 supply and compounding policies.
Is compounded semaglutide the same as Wegovy?
Compounded drugs are not FDA-approved and do not undergo the FDA’s premarket review for safety, effectiveness, and quality. They should not be described as equivalent to an FDA-approved product. The FDA recommends using compounded drugs only when a patient’s medical needs cannot be met by an FDA-approved drug. Compounding remains subject to specific requirements; a resolved shortage does not mean that every patient-specific compounded prescription is prohibited. Read the FDA’s guidance on unapproved GLP-1 drugs and discuss questions with your prescriber.
How can I compare treatment costs?
Before starting treatment, ask your insurer, pharmacy, and care team:
- Does my insurance plan cover the prescribed medication, and what prior authorization is required?
- What will I pay for the medication, consultations, follow-up visits, and any required testing?
- Are any manufacturer savings options available to me, and what are their eligibility rules and expiration dates?
- What other treatments may fit my medical history and budget if this medication is not covered?
Explore JourneyLite’s medical weight loss options, or compare weight loss treatments. Contact the team to confirm current offerings and fees before making a treatment decision.
Already using a prescribed medication?
Ask your prescriber or dispensing pharmacist for instructions specific to your medication and concentration. Do not use old online dosing charts or change your dose based on this article. The FDA has reported dosing errors involving compounded injectable semaglutide; its guidance linked above explains these concerns.
Request a JourneyLite consultation to discuss your options, or use the form below.
Appointment Request-Simple (Main)
"*" indicates required fields
